• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒感染患者的胰腺移植结果

Pancreas transplant outcomes in patients with human immunodeficiency virus infection.

作者信息

Bharadwaj Rashmi R, Orozco Gabriel, Mei Xiaonan, El-Haddad Hanine, Gedaly Roberto, Gupta Meera

机构信息

University of Kentucky College of Medicine, Lexington, Kentucky, USA.

Department of Surgery, University of Kentucky Transplant Center, University of Kentucky Healthcare, Lexington, Kentucky, USA.

出版信息

Am J Transplant. 2025 Apr;25(4):836-847. doi: 10.1016/j.ajt.2024.11.023. Epub 2024 Nov 29.

DOI:10.1016/j.ajt.2024.11.023
PMID:39615631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11974610/
Abstract

There is limited information on access and outcomes of patients living with human immunodeficiency virus (HIV) (PLWH) who have undergone pancreas transplantation. We conducted a retrospective cohort study analyzing data from the United Network for Organ Sharing from July 1, 2001, to June 30, 2021. Recipients of pancreas transplant were stratified by HIV serostatus. Graft and patient survival were analyzed using Kaplan-Meier product limit estimates. Multivariable Cox proportional hazard models were generated to identify factors associated with increased mortality or graft loss. Fifty PLWH and 16 380 patients without HIV underwent pancreas (with kidney) transplantation. PLWH were more often male (P < .001), Black/African American (P = .009), and on Medicare (P = .004). There were no significant differences in waiting time (P = .159) or proportion of patients treated for rejection within 1 year of transplant (P = .189) between groups. There were no differences in pancreas graft survival (P = .964) and overall patient survival (P = .250) between the cohorts. Dialysis status was negatively associated with graft survival. Although PLWH were more likely to represent a historically marginalized population, their outcomes after pancreas transplant were similar to their HIV-negative counterparts.

摘要

关于接受胰腺移植的人类免疫缺陷病毒(HIV)感染者(PLWH)的就医机会和治疗结果的信息有限。我们进行了一项回顾性队列研究,分析了2001年7月1日至2021年6月30日器官共享联合网络的数据。胰腺移植受者按HIV血清学状态分层。使用Kaplan-Meier乘积限估计法分析移植物和患者的生存率。生成多变量Cox比例风险模型,以确定与死亡率增加或移植物丢失相关的因素。50名PLWH和16380名未感染HIV的患者接受了胰腺(联合肾脏)移植。PLWH更常见于男性(P <.001)、黑人/非裔美国人(P =.009),且参加医疗保险(P =.004)。两组之间的等待时间(P =.159)或移植后1年内接受抗排斥治疗的患者比例(P =.189)没有显著差异。队列之间的胰腺移植物存活率(P =.964)和患者总体存活率(P =.250)没有差异。透析状态与移植物存活率呈负相关。虽然PLWH更有可能代表一个历史上被边缘化的人群,但他们胰腺移植后的结果与未感染HIV的患者相似。

相似文献

1
Pancreas transplant outcomes in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者的胰腺移植结果
Am J Transplant. 2025 Apr;25(4):836-847. doi: 10.1016/j.ajt.2024.11.023. Epub 2024 Nov 29.
2
Pancreas transplant outcomes in patients with human immunodeficiency virus infection.
Am J Transplant. 2025 Oct;25(10):2267-2276. doi: 10.1016/j.ajt.2025.06.001. Epub 2025 Jun 26.
3
A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.儿童肾移植免疫抑制治疗的临床及成本效益的系统评价与经济学模型
Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. doi: 10.3310/hta10490.
4
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.提高实体器官移植受者免疫抑制剂药物依从性的干预措施。
Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
5
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
6
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
7
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
8
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.用于肾移植受者诱导治疗的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD004759. doi: 10.1002/14651858.CD004759.pub2.
9
Antidepressants for depression in adults with HIV infection.用于感染HIV的成年抑郁症患者的抗抑郁药。
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3.
10
The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model.deceased donors: a systematic review and economic model. 存储已故捐赠者所捐肾脏方法的有效性和成本效益:一项系统综述与经济模型
Health Technol Assess. 2009 Aug;13(38):iii-iv, xi-xiv, 1-156. doi: 10.3310/hta13380.

本文引用的文献

1
Overcoming barriers and stigma: new frontiers in solid organ transplantation for people with HIV.克服障碍和污名:艾滋病毒感染者实体器官移植的新前沿。
Clin Microbiol Rev. 2024 Mar 14;37(1):e0011122. doi: 10.1128/cmr.00111-22. Epub 2024 Jan 19.
2
Expanding Access to Organ Transplant for People Living With HIV: Can Policy Catch Up to Outcomes Data?扩大艾滋病毒感染者器官移植的机会:政策能否跟上结果数据?
Transplantation. 2024 Apr 1;108(4):874-883. doi: 10.1097/TP.0000000000004794. Epub 2023 Sep 19.
3
Immunosuppression in HIV-positive kidney transplant recipients.HIV 阳性肾移植受者的免疫抑制
Curr Opin Organ Transplant. 2023 Aug 1;28(4):279-289. doi: 10.1097/MOT.0000000000001076. Epub 2023 May 23.
4
Reexamining the Impact of Insurance Type on Kidney Transplant Waitlist Status and Posttransplantation Outcomes in the United States After Implementation of the Affordable Care Act.《平价医疗法案》实施后美国保险类型对肾移植等待名单状态及移植后结果影响的重新审视
Transplant Direct. 2023 Jan 26;9(2):e1442. doi: 10.1097/TXD.0000000000001442. eCollection 2023 Feb.
5
Efficacy of pre-emptive kidney transplantation for adults with end-stage kidney disease: a systematic review and meta-analysis.预先性肾移植治疗终末期肾病成人患者的疗效:系统评价和荟萃分析。
Ren Fail. 2023 Dec;45(1):2169618. doi: 10.1080/0886022X.2023.2169618.
6
Efficacy of hope: Analysis of organ quality and availability among deceased HIV-positive donors.希望的疗效:对已故 HIV 阳性供体器官质量和可用性的分析。
Transpl Infect Dis. 2022 Dec;24(6):e13916. doi: 10.1111/tid.13916. Epub 2022 Aug 12.
7
Long-term Outcomes Following Kidney and Liver Transplant in Recipients With HIV.HIV 感染者肾肝联合移植的长期预后。
JAMA Surg. 2022 Mar 1;157(3):240-247. doi: 10.1001/jamasurg.2021.6798.
8
From race-based to race-conscious medicine: how anti-racist uprisings call us to act.从基于种族的医学到关注种族的医学:反种族主义起义如何呼吁我们采取行动。
Lancet. 2020 Oct 10;396(10257):1125-1128. doi: 10.1016/S0140-6736(20)32076-6.
9
Long-term follow-up of beta cell replacement therapy in 10 HIV-infected patients with renal failure secondary to type 1 diabetes mellitus.10 例 1 型糖尿病继发肾衰竭合并 HIV 感染患者胰岛细胞移植后的长期随访。
Am J Transplant. 2020 Aug;20(8):2091-2100. doi: 10.1111/ajt.15796. Epub 2020 Feb 28.
10
Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis.HIV 阳性患者的肾移植结局:系统评价和荟萃分析。
AIDS Res Ther. 2019 Nov 20;16(1):37. doi: 10.1186/s12981-019-0253-z.